(Reuters) – U.S. President Joe Biden’s administration on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson (NYSE:)’s COVID-19 vaccine from making one other vaccine developed by AstraZeneca (NASDAQ:), the New York Times reported on Saturday.
The administration has put Johnson & Johnson answerable for the troubled manufacturing plant, the report stated.
The U.S. Health and Human Services’ extraordinary step will render the Emergent BioSolutions facility solely devoted to creating the Johnson & Johnson single-dose vaccine, and is supposed to keep away from future combine-ups, in response to the report, which cites two senior federal well being officers.
Johnson & Johnson stated it was “assuming full responsibility”, confirming the modifications, the report added.
Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or injury because of reliance on the data together with knowledge, quotes, charts and purchase/promote indicators contained inside this website. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is without doubt one of the riskiest funding varieties doable.